British American Tobacco p.l.c. (BTI)
ValueMarkers Composite Index
72% below intrinsic value ($205)
British American Tobacco p.l.c. (BTI) — VMCI valuation read
Headline read on BTI: VMCI of 54/100 versus a Consumer Defensive sector median of 50. The 4-point above-median position is what makes British American Tobacco p.l.c. a relative-value candidate in the mid-cap cohort, before any pillar-level review.
Form 4 filings on BTI: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.
**Investor frame.** Three reads on BTI: value (BTI trades at 27.0x earnings, 50% above the Consumer Defensive median of 18.0x), quality (ROIC of 11.0% sits 1.0pp above the Consumer Defensive median (10.0%)), and risk (net debt to EBITDA of -1.1x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the Consumer Defensive 12.0x baseline.
BTI rose 2.4% over the trailing 7 days, with a -21.0% read on a 30-day basis.
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
Related Stocks in Consumer Defensive
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.